Otsuka Holdings
4578.T
#596
Rank
โ‚น3.791 T
Marketcap
โ‚น7,241
Share price
0.95%
Change (1 day)
53.89%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2026 (TTM): โ‚น307.78

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น328.59. In 2025 the company made an earnings per share (EPS) of โ‚น408.55 an increase over its 2024 EPS that were of โ‚น376.55.

EPS history for Otsuka Holdings from 2009 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น307.78-24.67%
2025โ‚น408.558.5%
2024โ‚น376.55153.9%
2023โ‚น148.31-15.71%
2022โ‚น175.94-6.18%
2021โ‚น187.53-24.1%
2020โ‚น247.0822.95%
2019โ‚น200.9656.13%
2018โ‚น128.71-25.11%
2017โ‚น171.8825.99%
2016โ‚น136.43-6.37%
2015โ‚น145.72
2014N/A-100%
2013โ‚น219.5418.06%
2012โ‚น185.951.01%
2011โ‚น184.0929.07%
2010โ‚น142.63-94.47%
2009โ‚น2,578